revolutionari
technolog
genom
edit
known
cluster
regularli
interspac
short
palindrom
repeat
crispr
crisprassoci
protein
system
spark
advanc
biolog
biomed
research
scientif
breakthrough
develop
technolog
allow
us
recapitul
human
diseas
gener
anim
model
interest
rang
zebrafish
nonhuman
primat
system
also
use
delin
mechan
underli
develop
human
disord
precis
correct
diseasecaus
mutat
repurpos
technolog
enabl
wider
applic
transcriptom
epigenom
manipul
hold
promis
reach
clinic
review
highlight
latest
advanc
system
differ
platform
discuss
hurdl
challeng
technolog
face
nucleas
zfn
transcript
activatorlik
effector
nucleas
talen
enabl
manipul
gene
target
dna
doublestrand
break
dsb
via
nonhomolog
endjoin
nhej
homologydirect
repair
hdr
pathway
rudin
et
al
rouet
et
al
choulika
et
al
bibikova
et
al
moscou
bogdanov
nhejmedi
errorpron
dna
repair
gener
insertiondelet
indel
site
break
disrupt
translat
read
frame
lead
frameshift
mutat
altern
dna
damag
repair
hdr
pathway
dna
templatedepend
manner
result
precis
gene
insert
correct
fig
despit
advanc
wider
adopt
technolog
limit
low
specif
complex
procedur
sanchezrivera
jack
past
sever
year
revolutionari
technolog
genom
edit
cluster
regularli
interspac
short
palindrom
repeat
crispr
crisprassoci
protein
system
achiev
great
accomplish
worldwid
develop
system
open
new
era
precis
genom
manipul
almost
reach
clinic
go
stottmann
crispr
stori
began
japanes
group
report
odd
repeat
sequenc
space
ishino
et
al
thereaft
scientist
spent
nearli
year
identifi
crispr
part
adapt
immun
system
defend
invad
infect
lander
three
type
crispr
system
type
ii
crispr
nucleas
system
simplest
genom
edit
technolog
requir
protein
two
rna
crispr
rna
crrna
transactiv
crrna
tracrrna
broun
et
al
wiedenheft
et
al
jinek
et
al
nativ
system
nucleas
guid
duplex
form
crrna
contain
region
dna
bind
tracrrna
activ
cleav
dna
barrang
et
al
target
recognit
dna
cleavag
requir
presenc
protospaceradjac
motif
pam
consensu
ngg
nag
sequenc
adjac
end
target
dna
gasiuna
et
al
jinek
et
al
crrna
tracrrna
duplex
simplifi
program
chimer
singleguid
rna
sgrna
direct
nucleas
creat
dsb
dna
desir
posit
interest
jinek
et
al
mali
et
al
fig
develop
facilit
target
dna
simpli
design
sgrna
introduc
presenc
protein
experiment
protocol
sgrna
design
construct
welldocu
shalem
et
al
scientist
attempt
appli
system
multipl
organ
rang
zebrafish
hwang
et
al
drosophila
akiyama
gibson
mosquito
hammond
et
al
rodent
jackson
et
al
soda
et
al
li
et
al
maddalo
et
al
dog
zou
et
al
pig
redel
prather
park
et
al
nonhuman
primat
niu
et
al
chen
et
al
compar
convent
embryon
stem
cell
esc
manipul
gene
edit
esc
dramat
increas
gene
edit
effici
reduc
time
requir
year
month
fellmann
et
al
addit
target
singl
gene
technolog
extend
simultan
disrupt
five
gene
mous
esc
high
effici
one
step
wang
et
al
find
well
later
report
induc
mous
model
platform
facilit
rapid
gener
larg
repositori
esc
unpreced
speed
precis
sanchezrivera
jack
altern
appropri
design
sgrna
directli
microinject
simpli
electropor
fertil
zygot
achiev
herit
gene
modif
coinject
mrna
sgrna
mous
zygot
result
total
mice
carri
biallel
mutat
target
gene
importantli
model
gener
month
much
shorter
time
take
use
convent
method
gene
target
esc
wang
et
al
last
year
one
research
team
report
gener
robust
mous
model
middl
east
respiratori
syndrom
coronaviru
merscov
cockrel
et
al
small
anim
model
natur
resist
merscov
author
introduc
two
human
mutat
posit
mous
gene
via
pronuclear
microinject
fertil
zygot
make
mice
highli
suscept
merscov
infect
replic
discoveri
hold
great
promis
field
therapeut
design
offer
new
strategi
combat
emerg
virus
near
futur
addit
mice
edit
perform
target
malaria
mosquito
embryo
lead
malaria
erad
either
impair
fertil
femal
mosquito
hammond
et
al
insert
antimalari
gene
malaria
mosquito
recent
research
reveal
first
porcin
model
directli
inject
ribonucleoprotein
complex
sgrna
sequenc
porcin
zygot
park
et
al
zoolog
expert
china
extend
applic
system
monkey
target
onecellstag
embryo
niu
et
al
gener
primat
model
duchenn
muscular
dystrophi
dmd
chen
et
al
promis
model
faith
recapitul
human
diseas
pave
way
better
understand
diseas
identifi
vaccin
drug
high
efficaci
human
repair
nonhomolog
endjoin
nhej
homologydirect
repair
hdr
nhej
repair
pathway
result
random
insertiondelet
indel
site
break
lead
frameshift
mutat
hdrmediat
pathway
achiev
precis
gene
insertioncorrect
presenc
donor
dna
templat
b
endonucleas
dark
tan
guid
crrna
tracrrna
duplex
specif
target
dna
sequenc
adjac
protospaceadjac
motif
pam
dark
blue
crrna
tracrrna
duplex
simplifi
chimer
singleguid
rna
sgrna
yellow
direct
protein
creat
dsb
desir
posit
dna
target
therebi
stimul
intracellular
dna
repair
pathway
nonetheless
genom
edit
zygot
alway
caus
genet
mosaic
even
embryon
lethal
make
zygot
difficult
assess
manipul
fellmann
et
al
hand
germlin
edit
infeas
human
embryo
due
bioethic
concern
olson
limit
allow
research
directli
perform
somat
genom
edit
ex
vivo
vivo
within
certain
tissu
adult
anim
malina
et
al
first
report
ex
vivo
disrupt
emmyc
mous
model
subsequ
sever
lead
group
report
ex
vivo
somat
genom
edit
mice
model
hematolog
malign
heckl
et
al
find
highlight
feasibl
use
ex
vivo
genom
edit
model
human
cancer
jack
group
success
deliv
plasmid
encod
sgrna
directli
murin
liver
cell
vivo
deliv
allinon
lentivirus
express
crispr
compon
murin
lung
cell
sanchezrivera
et
al
later
year
anoth
group
mimick
oncogen
chromosom
transloc
vivo
use
adenoviralmedi
deliveri
system
wildtyp
mice
maddalo
et
al
meanwhil
research
note
viral
nonvir
nanoparticlesgrna
deliveri
method
effici
facilit
genom
edit
multipl
murin
tissu
vivo
includ
neuron
immun
cell
lung
endotheli
cell
platt
et
al
scienc
simultan
publish
three
excit
vivo
somat
geneedit
studi
use
mous
model
dmd
fatal
xlink
recess
inherit
diseas
caus
mutat
human
dystrophin
dmd
gene
long
et
al
nelson
et
al
tabebordbar
et
al
lack
function
dmd
protein
lead
progress
muscl
deterior
effect
treatment
develop
use
dmd
mous
model
harbor
nonsens
mutat
exon
dmd
gene
research
develop
adenoassoci
viru
aav
mediat
strategi
restor
express
truncat
dmd
variant
excis
exon
amazingli
amount
dmd
express
could
restor
could
enough
provid
potenti
therapeut
benefit
human
koch
although
safeti
efficaci
system
administr
aav
vector
well
risk
offtarget
integr
still
need
assess
vandendriessch
chuah
overal
studi
empow
broader
rang
diseas
model
applic
via
genom
engin
allow
research
uncov
fundament
mechan
diseas
initi
mainten
process
explor
therapeut
potenti
system
correct
diseasecaus
mutat
applic
strategi
gener
anim
model
summar
figur
despit
excit
advanc
gener
vivo
model
applic
date
limit
bench
studi
due
streamlin
straightforward
process
introduct
target
knockout
simplest
way
delin
role
certain
gene
precis
flexibl
edit
tool
complet
silenc
mutagenesi
overwhelmingli
appli
biolog
biomed
field
throughout
world
unlik
rna
interfer
rnai
base
silenc
limit
partial
deplet
target
gene
level
enabl
complet
loss
gene
function
nhejmedi
error
prone
repair
moreov
system
work
cell
cultur
system
similar
manner
major
differ
deliveri
method
system
fellmann
et
al
exampl
transient
transfect
plasmid
encod
sgrna
cell
report
mani
studi
cho
et
al
cong
et
al
mali
et
al
contrast
virusbas
stabl
deliveri
effici
way
modifi
cell
especi
hardtotransfect
blood
cell
tagd
et
al
zhang
et
al
b
human
cancer
target
diseas
use
technolog
isogen
knockout
cell
allow
rapid
identif
caus
role
oncogen
tumor
suppressor
exclud
interfer
addit
faster
econom
reprogram
abil
provid
excit
opportun
unravel
mechan
drug
resist
identifi
potenti
therapeut
target
last
year
one
research
group
unveil
oncogen
featur
transglutaminas
mantl
cell
lymphoma
mcl
use
lentiviralbas
knockout
system
uncov
posit
feedback
loop
involv
signal
autophagi
zhang
et
al
disrupt
network
may
promis
therapeut
target
introduc
novel
strategi
overcom
chemoresist
mcl
zhang
mccarti
recent
multicent
team
identifi
novel
mechanist
contribut
glucos
transport
inhibitor
txnip
prebcel
acut
lymphoblast
leukemia
gene
downstream
target
highli
induc
delet
gene
significantli
enhanc
glucos
uptak
increas
atp
level
reveal
import
function
metabol
gatekeep
provid
promis
therapeut
target
anoth
illustr
exampl
applic
genom
edit
tool
modifi
chimer
antigen
receptor
car
cell
emerg
power
therapi
treat
variou
hematolog
malign
mau
et
al
prevent
unwant
respons
car
cell
immunotherapi
graftversushost
diseas
gvhd
graft
reject
research
attempt
knock
endogen
cell
receptor
tcr
gene
use
zfn
talen
genom
edit
torikai
et
al
qasim
et
al
last
year
one
chines
group
first
inject
cell
back
patient
metastat
lung
cancer
research
disabl
gene
encod
program
cell
death
protein
prevent
cell
attack
cell
without
edit
cell
defeat
attack
cancer
howev
efficaci
crispren
attack
fulli
determin
month
observ
cyranoski
major
limit
cell
line
adapt
chang
caus
secondari
mutat
two
recent
public
report
unexpect
result
research
show
human
immunodefici
viru
hiv
evolut
escap
crispr
geneprogram
attack
due
mutat
wang
et
al
b
deep
sequenc
analysi
show
mutat
gener
cellular
nhej
mutagenesi
cleavag
site
indel
result
chang
target
dna
sequenc
therebi
prevent
sgrna
bind
ultim
lead
resist
wang
et
al
find
highlight
import
strategi
solut
overcom
viral
resist
system
liang
et
al
owe
abil
complet
disrupt
target
gene
simplic
design
potent
sgrna
system
extend
largescal
lossoffunct
lof
genom
screen
human
cell
koikeyusa
et
al
shalem
et
al
wang
et
al
zhou
et
al
one
pioneer
studi
establish
lentivirusmedi
librari
contain
sgrna
gener
knockout
collect
genomewid
screen
myeloid
leukemia
cell
follow
year
group
identifi
essenti
gene
requir
cell
prolifer
surviv
four
leukemia
lymphoma
cell
line
compar
rnaibas
screen
screen
achiev
robust
hit
exhibit
significantli
lower
falseneg
rate
munoz
et
al
nonetheless
one
studi
highlight
import
combin
data
rnai
screen
morgen
et
al
studi
author
perform
parallel
rnai
screen
identifi
essenti
gene
human
chronic
myelogen
leukemia
cml
cell
line
although
rnai
screen
achiev
similar
level
precis
numer
identifi
gene
overlap
two
screen
observ
suggest
rnai
screen
detect
distinct
aspect
biolog
one
plausibl
reason
certain
gene
partial
knock
lead
total
differ
phenotyp
compar
result
complet
loss
via
knockout
recent
one
team
stanford
univers
develop
crisprbas
doubl
knockout
system
disabl
two
gene
one
time
cell
use
modifi
system
knock
pair
drug
target
leukemia
cell
identifi
synthet
lethal
drug
target
pair
work
demonstr
promis
highthroughput
crisprbas
fig
applic
system
diseas
model
germlin
edit
achiev
electropor
embryon
stem
cell
esc
valid
expand
inject
host
blastocyst
altern
crispr
compon
introduc
direct
microinject
fertil
zygot
addit
germlin
edit
primari
stemprogenitor
cell
ex
vivo
manipul
expand
prior
transplant
somat
cell
edit
reagent
also
deliv
certain
host
tissu
eg
liver
lung
brain
via
local
inject
crispr
strategi
allow
direct
accur
recapitul
human
diseas
offer
potenti
therapeut
benefit
human
screen
tool
determin
function
pairwis
genet
interact
han
et
al
one
keep
mind
genotox
stress
induc
larg
number
dna
break
perform
crisprbas
lof
screen
two
independ
experi
note
genom
target
highli
amplifi
region
lead
increas
dna
damag
profound
antiprolif
respons
reveal
unanticip
class
falseposit
hit
aguirr
et
al
munoz
et
al
find
alarm
crisprbas
screen
highli
amplifi
loci
regard
appropri
sgrna
design
care
control
make
excess
genom
cut
urgent
need
anoth
import
challeng
knockout
system
cell
lethal
earli
stage
caus
loss
essenti
gene
one
solut
use
temperaturesensit
mutant
allel
recent
welldescrib
housden
et
al
induc
system
provid
altern
option
identifi
biolog
function
critic
gene
zhang
mccarti
compar
nhejmedi
gene
disrupt
hdrinduc
gene
correct
broader
applic
spectrum
although
hdr
pathway
less
effici
mammalian
cell
human
inherit
disord
bhemoglobinopathi
ie
bthalassemia
sickl
cell
diseas
dever
et
al
traxler
et
al
ye
et
al
park
et
al
anemia
bluteau
et
al
osborn
et
al
coagul
disord
guan
et
al
park
et
al
repres
ideal
target
gene
therapi
partial
restor
gene
correct
suffici
revers
symptom
addit
blood
disord
extens
discuss
detail
zhang
mccarti
diseasecaus
mutat
precis
target
correct
use
one
group
repair
mutat
cystic
fibrosi
transmembran
conductor
receptor
cftr
locu
via
hdr
primari
intestin
stem
cell
deriv
cystic
fibrosi
patient
singlegen
hereditari
defect
schwank
et
al
later
hdrinduc
gene
correct
success
appli
effici
correct
mutat
phenotyp
mous
model
hereditari
tyrosinemia
yin
et
al
hear
loss
miann
et
al
eye
diseas
kim
et
al
recent
one
research
team
fulli
replac
instead
excis
defect
mutat
introduc
aavmedi
crispr
compon
dmd
homolog
region
mous
model
dmd
bengtsson
et
al
inde
approach
allow
replac
mutat
correct
sequenc
regardless
move
gene
correct
bench
clinic
long
way
go
reason
human
immun
system
may
recogn
correct
protein
foreign
thu
elimin
protein
cytotox
lymphocyt
ii
phenotyp
edit
cell
may
fulli
reflect
actual
respons
human
sinc
epigenet
microenviron
alter
consid
simpl
ex
vivo
vitro
experi
iii
despit
success
model
vivo
mani
uncertain
safeti
issu
deliveri
effici
remain
unaddress
human
fellmann
et
al
housden
et
al
expand
potenti
system
weissman
group
introduc
two
mutat
ruvc
hnh
site
endonucleas
creat
catalyt
inact
protein
endonucleas
activ
repurpos
system
call
crispr
interfer
crispri
system
effici
repress
express
target
gene
directli
block
transcript
initi
elong
offtarget
effect
unlik
perman
genet
modif
induc
endonucleas
crisprimedi
gene
repress
induc
revers
offer
adjust
platform
rnaguid
transcript
regul
achiev
enhanc
transcript
regul
research
fuse
either
repressor
domain
krab
uppel
associ
box
activ
domain
four
copi
activ
result
system
capabl
repress
crispri
activ
crispra
transcript
target
gene
fig
crispria
approach
optim
control
transcript
level
endogen
gene
includ
noncod
transcript
across
high
dynam
rang
importantli
crispria
use
rapidli
screen
lof
gainoffunct
gof
phenotyp
pool
set
provid
complementari
inform
map
complex
pathway
yet
achiev
contrast
konermann
et
al
develop
independ
crispra
system
mediat
synergist
activ
mediat
sam
complex
consist
multipl
distinct
transcript
activ
thu
achiev
robust
gene
upregul
mediat
singl
sgrna
advanc
facilit
wholetranscriptom
control
human
genom
help
discov
therapeut
target
genomescal
crispria
screen
heckl
charpenti
amazingli
repress
activ
gene
simultan
achiev
use
program
scaffold
rna
scrna
encod
target
dna
regulatori
effector
zalatan
et
al
strategi
enabl
simultan
control
multipl
gene
cell
turn
one
set
gene
turn
anoth
set
thu
offer
wide
rang
biomed
biotechnolog
use
koch
given
uncompl
design
versatil
featur
crispria
method
appli
multipl
organ
instanc
crispri
extens
use
repress
multipl
gene
mycobacterium
choudhari
et
al
cyanobacterium
corynebacterium
glutamincum
cleto
et
al
escherichia
coli
kim
et
al
thu
capabl
regul
molecul
interest
bacteri
microb
meanwhil
multipl
anim
model
worm
zebrafish
rossi
et
al
success
gener
use
crispri
soon
studi
simpl
organ
approach
exploit
precis
modul
endogen
gene
express
human
breast
cancer
cell
shen
et
al
human
induc
pluripot
stem
cell
ipsc
deriv
neuron
hemanackah
et
al
recent
one
group
netherland
compar
perform
crispr
crispri
tradit
short
hairpin
rna
shrna
system
abil
identifi
essenti
gene
human
bladder
cancer
cell
ever
et
al
interestingli
found
crisprbas
knockout
system
outperform
crispriand
shrnabas
technolog
discrimin
hit
nonhit
function
genet
screen
low
nois
absenc
offtarget
effect
better
consist
across
cell
line
likewis
crispra
method
util
creat
vivo
model
drosophila
worm
zebrafish
addit
typic
activ
secondgener
activ
test
across
multipl
cell
type
speci
chavez
et
al
particular
three
activ
suntag
tanenbaum
et
al
vpr
chavez
et
al
sam
konermann
et
al
appear
potent
system
compar
studi
provid
extens
set
system
gener
reliabl
tool
improv
activ
especi
highli
repress
gene
although
use
crispra
method
thu
far
limit
preliminari
function
studi
guo
et
al
koirala
et
al
recent
group
univers
oxford
report
novel
design
spacerblock
hairpin
sbh
structur
end
sgrna
ferri
et
al
strategi
abrog
function
crispr
transcript
activ
replac
sbh
loop
condit
rnacleav
unit
enabl
induc
sbh
isbh
platform
modul
crispra
effect
presenc
specif
induc
isbhbas
crispr
system
present
versatil
simpl
plug
play
tool
accur
condit
activ
cripsrbas
system
differ
diseas
state
enrich
design
complex
network
research
therapeut
purpos
apart
use
transcript
modul
util
alter
epigenet
mark
remodel
aberr
epigenet
landscap
two
group
fuse
histon
demethylas
kearn
et
al
acetyltransferas
hilton
et
al
target
enhanc
promot
thu
lead
robust
chang
gene
express
anoth
group
target
distal
enhanc
dnase
ihypersensit
site
dh
result
highli
specif
histon
methyl
enhanc
decreas
chromatin
access
enhanc
associ
promot
recent
one
team
develop
crisprbas
tool
specif
increas
cpg
methyl
fuse
catalyt
domain
dna
methyltransferas
enabl
methyl
larger
part
promot
genom
mammalian
cell
vojta
et
al
furthermor
crisprbas
epigenom
edit
recent
use
highthroughput
lofgof
screen
regulatori
element
human
genom
serv
highli
scalabl
platform
epigenom
engin
klann
et
al
studi
strengthen
potenti
system
target
regulatori
region
rather
target
gene
provid
power
tool
dissect
regulatori
network
coordin
gene
express
fig
beyond
gene
edit
regul
anoth
urgent
challeng
field
cell
biolog
effici
label
trace
specif
dna
sequenc
within
live
cell
although
convent
fluoresc
situ
hybrid
fish
develop
last
decad
overcom
hurdl
scientist
repurpos
system
genom
imag
tool
imag
live
human
cell
chen
et
al
crispr
imag
system
consist
enhanc
green
fluoresc
protein
egfp
tag
protein
optim
sgrna
enabl
robust
imag
repetit
element
telomer
proteincod
gene
allow
visual
arbitrari
nonrepetit
genom
sequenc
human
genom
fig
undoubtedli
new
crisprbas
imag
technolog
serv
complementari
approach
fish
allow
simpler
direct
track
telomer
dynam
subnuclear
local
chromatin
organ
throughout
cell
cycl
system
later
report
live
mous
embryon
stem
cell
anton
et
al
unlik
previou
studi
mainli
focus
detect
sensit
chen
et
al
anton
et
al
perform
thorough
comparison
crisprbas
imag
method
immunelabel
method
explor
potenti
applic
use
crisprbas
imag
technolog
high
resolut
microscopi
studi
later
year
tanenbaum
et
al
develop
synthet
suntag
system
recruit
copi
gfp
target
polypeptid
chain
use
modifi
tag
suntag
author
creat
nearli
brighter
fluoresc
signal
result
directli
fuse
gfp
thu
provid
magnifi
fluoresc
imag
platform
live
cell
subsequ
variant
fuse
differ
fluoresc
protein
introduc
human
cell
allow
simultan
detect
multipl
color
genom
loci
high
spatial
resolut
distanc
two
loci
chromosom
also
map
use
strategi
et
al
addit
one
group
achiev
imag
lowand
nonrepetit
chromosom
loci
integr
sgrna
motif
enabl
robust
fluoresc
signal
amplif
qin
et
al
recent
research
even
paint
entir
chromosom
introduc
hundr
specif
nonrepetit
sgrna
live
cell
fluoresc
imag
amazingli
arrang
homolog
chromosom
well
movement
particular
chromosom
divid
cell
could
clearli
visual
zhou
et
al
overal
crisprbas
imag
tool
facilit
model
spatiotempor
dynam
differ
cell
stage
enabl
panorama
interact
genom
loci
within
live
human
cell
addit
target
doublestrand
dna
dsdna
system
revolutionarili
develop
cleav
singlestrand
rna
ssrna
specif
target
site
provid
pam
part
oligonucleotid
pammer
hybrid
target
rna
fig
system
enabl
recogn
cleav
rna
target
programm
fashion
facilit
direct
transcript
detect
oconnel
et
al
hand
system
may
help
altern
rnai
use
rna
degrad
ghodsizadeh
last
year
group
develop
rnatarget
fluorescencebas
probe
track
rna
live
cell
nell
et
al
fig
innov
strategi
allow
recogn
rna
avoid
encod
dna
importantli
subcellular
distribut
highli
correl
rnafish
depict
abil
track
traffick
local
rna
live
cell
method
lay
solid
foundat
transcriptom
edit
enabl
scientist
measur
divers
transcript
type
multipl
cell
system
manipul
target
rna
detect
rna
also
alter
rna
modif
burgess
addit
type
ii
system
scientist
uncov
featur
type
crisprca
system
compris
approxim
crisprca
loci
identifi
bacteria
archaea
target
dna
rna
makarova
et
al
beyond
track
rna
live
cell
futur
develop
system
modul
multipl
rnaprocess
step
gener
diseas
model
promot
clinic
translat
deserv
explor
although
tool
adopt
across
numer
field
worldwid
challeng
regard
ethic
concern
clinic
applic
underscor
olson
success
benchtob
translat
reli
effici
deliveri
system
refin
administr
procedur
target
human
diseas
high
specif
respect
appli
edit
larg
anim
speci
dog
pig
nonhuman
primat
help
gain
better
understand
human
diseas
provid
comprehens
safeti
report
therapeut
strategi
one
note
adapt
evolutionari
chang
pathogen
virus
may
develop
anticrispr
strategi
escap
crisprmedi
attack
result
treatment
failur
despit
unaddress
barrier
function
research
strengthen
grasp
potenti
underpin
initi
develop
human
diseas
inspiringli
novel
edit
tool
deaminas
komor
et
al
nucleas
zetsch
et
al
kim
et
al
demonstr
unlimit
possibl
use
crispr
technolog
genom
edit
defin
unpreced
path
next
gener
transform
therapi
treatment
forese
futur
